Skip to main content

previous disabled Page of 18
and
Your search also matched 33 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Treatment and survival for patients with localized primary ocular adnexal extranodal marginal zone lymphoma

Include preview-only content
  1. Article

    Open Access

    Survival of advanced/recurrent gastrointestinal stromal tumors treated with tyrosine kinase inhibitors in Taiwan: a nationwide registry study

    Most gastrointestinal stromal tumors (GISTs) harbor c-KIT or PDGFRA mutations. Administration of tyrosine kinase inhibitors (TKIs) has significantly improved the survival of patients with GISTs. We aimed to evalu...

    Hui-Jen Tsai, Yan-Shen Shan, Ching-Yao Yang, Chin-Fu Hsiao, Chung-Hsin Tsai in BMC Cancer (2024)

  2. Article

    Open Access

    Clinical efficacy and identification of factors confer resistance to afatinib (tyrosine kinase inhibitor) in EGFR-overexpressing esophageal squamous cell carcinoma

    Epidermal growth factor receptor (EGFR) is reportedly overexpressed in most esophageal squamous cell carcinoma (ESCC) patients, but anti-EGFR treatments offer limited survival benefits. Our preclinical data sh...

    Yanni Wang, Chang Liu, Huan Chen, ** Jiao in Signal Transduction and Targeted Therapy (2024)

  3. Article

    Open Access

    Targeting a disintegrin and metalloprotease (ADAM) 17-CD122 axis enhances CD8+ T cell effector differentiation and anti-tumor immunity

    CD8+ T cell immune responses are regulated by multi-layer networks, while the post-translational regulation remains largely unknown. Transmembrane ectodomain shedding is an important post-translational process or...

    Lina Sun, Anjun Jiao, Haiyan Liu, Renyi Ding in Signal Transduction and Targeted Therapy (2024)

  4. Article

    Open Access

    Targeted inhibition of DHODH is synergistic with BCL2 blockade in HGBCL with concurrent MYC and BCL2 rearrangement

    High-grade B-cell lymphoma (HGBCL), the subtype of non-Hodgkin lymphoma, to be relapsed or refractory in patients after initial therapy or salvage chemotherapy. Dual dysregulation of MYC and BCL2 is one of the...

    Lin Liu, Wenbin Mo, Miao Chen, Yi Qu, **** Wang, Ying Liang, **ao**g Yan in BMC Cancer (2024)

  5. Article

    Open Access

    Penpulimab, an anti-PD-1 antibody, for heavily pretreated metastatic nasopharyngeal carcinoma: a single-arm phase II study

    Penpulimab is an anti-programmed cell death-1 (PD-1) IgG1 antibody with no Fc gamma receptor (FcγR) binding activity, and thus theoretically reduced immune-related adverse events (irAEs) while maintaining effi...

    **aozhong Chen, Wei Wang, Qingfeng Zou in Signal Transduction and Targeted Therapy (2024)

  6. Article

    Open Access

    Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets

    Tumorigenesis is a multistep process, with oncogenic mutations in a normal cell conferring clonal advantage as the initial event. However, despite pervasive somatic mutations and clonal expansion in normal tis...

    Shaosen Zhang, **nyi **ao, Yonglin Yi in Signal Transduction and Targeted Therapy (2024)

  7. Article

    Open Access

    Antitumor efficacy and potential mechanism of FAP-targeted radioligand therapy combined with immune checkpoint blockade

    Radiotherapy combined with immune checkpoint blockade holds great promise for synergistic antitumor efficacy. Targeted radionuclide therapy delivers radiation directly to tumor sites. LNC1004 is a fibroblast a...

    Liang Zhao, Yizhen Pang, Yangfan Zhou in Signal Transduction and Targeted Therapy (2024)

  8. Article

    Open Access

    Immunotherapy combined with apatinib in the treatment of advanced or metastatic gastric/gastroesophageal tumors: a systematic review and meta-analysis

    Immunotherapy or apatinib alone has been used as third-line adjuvant therapy for advanced or metastatic gastric/gastroesophageal junction (G/GEJ) tumors, but the efficacy of combining them with each other for ...

    **cheng Wang, Jie Lin, Ruimin Wang, Ti Tong, Yinghao Zhao in BMC Cancer (2024)

  9. Article

    Open Access

    Sintilimab (anti-PD-1 antibody) plus chidamide (histone deacetylase inhibitor) in relapsed or refractory extranodal natural killer T-cell lymphoma (SCENT): a phase Ib/II study

    Anti-PD-1 antibodies are a favorable treatment for relapsed or refractory extranodal natural killer T cell lymphoma (RR-ENKTL), however, the complete response (CR) rate and the duration of response (DOR) need ...

    Yan Gao, Haixia He, Xue** Li, Liling Zhang in Signal Transduction and Targeted Therapy (2024)

  10. Article

    Open Access

    Nasal vaccination of triple-RBD scaffold protein with flagellin elicits long-term protection against SARS-CoV-2 variants including JN.1

    Develo** a mucosal vaccine against SARS-CoV-2 is critical for combatting the epidemic. Here, we investigated long-term immune responses and protection against SARS-CoV-2 for the intranasal vaccination of a t...

    **an Li, Mengxin Xu, **gyi Yang, Li Zhou in Signal Transduction and Targeted Therapy (2024)

  11. Article

    Open Access

    Ferroptosis-related lncRNA NRAV affects the prognosis of hepatocellular carcinoma via the miR-375-3P/SLC7A11 axis

    Ferroptosis has important value in cancer treatment. It is significant to explore the new ferroptosis-related lncRNAs prediction model in Hepatocellular carcinoma (HCC) and the potential molecular mechanism of...

    Ke Zong, Caifeng Lin, Kai Luo, Yilei Deng, Hongfei Wang, Jianfei Hu, Shi Chen in BMC Cancer (2024)

  12. Article

    Open Access

    Mex-3 RNA binding family member A (MEX3A)/circMPP6 complex promotes colorectal cancer progression by inhibiting autophagy

    RNA-binding proteins (RBPs)-RNA networks have contributed to cancer development. Circular RNAs (circRNAs) are considered as protein recruiters; nevertheless, the patterns of circRNA-protein interactions in col...

    Ri-**n Chen, Shui-Dan Xu, Min-Hua Deng in Signal Transduction and Targeted Therapy (2024)

  13. Article

    Open Access

    Deep learning on tertiary lymphoid structures in hematoxylin-eosin predicts cancer prognosis and immunotherapy response

    Tertiary lymphoid structures (TLSs) have been associated with favorable immunotherapy responses and prognosis in various cancers. Despite their significance, their quantification using multiplex immunohistoche...

    Ziqiang Chen, **aobing Wang, Zelin **, Bosen Li, Dongxian Jiang in npj Precision Oncology (2024)

  14. Article

    Open Access

    ART1 knockdown decreases the IL-6-induced proliferation of colorectal cancer cells

    Colorectal cancer (CRC) is a worldwide health concern. Chronic inflammation is a risk factor for CRC, and interleukin-6 (IL-6) plays a pivotal role in this process. Arginine-specific mono-ADP-ribosyltransferas...

    Ting Lin, Shuxian Zhang, Yi Tang, Ming **ao, Ming Li, Hanjuan Gong in BMC Cancer (2024)

  15. Article

    Open Access

    Is low-dose computed tomography for lung cancer screening conveniently accessible in China? A spatial analysis based on cross-sectional survey

    Regular Low-Dose Computed Tomography (LDCT) for lung cancer high-risk population has been proved to improve health outcomes and relieve disease burden efficiently for both individual and society. With geograph...

    Jay Pan, Jianjian Wang, Wenjuan Tao, Chaohui Wang, **aojun Lin, **uli Wang in BMC Cancer (2024)

  16. Article

    Open Access

    ST14 interacts with TMEFF1 and is a predictor of poor prognosis in ovarian cancer

    TMEFF1 is a new protein involved in the physiological functions of the central nervous system, and we previously reported TMEFF1 can promote ovarian cancer. ST14 was determined to be involved in the processes ...

    **n Nie, Lingling Gao, Mingjun Zheng, Shuang Wang, Caixia Wang, **ao Li in BMC Cancer (2024)

  17. Article

    Open Access

    A functional personalised oncology approach against metastatic colorectal cancer in matched patient derived organoids

    Globally, colorectal cancer (CRC) is the third most frequently occurring cancer. Progression on to an advanced metastatic malignancy (metCRC) is often indicative of poor prognosis, as the 5-year survival rates...

    Dexter Kai Hao Thng, Lissa Hooi, Bei En Siew, Kai-Yin Lee in npj Precision Oncology (2024)

  18. Article

    Open Access

    Prognostic value of GLIM-defined malnutrition in combination with hand-grip strength or gait speed for the prediction of postoperative outcomes in gastric cancer patients with cachexia

    Cancer cachexia is associated with impaired functional and nutritional status and worse clinical outcomes. Global Leadership Initiative in Malnutrition (GLIM) consensus recommended the application of GLIM crit...

    Zong-Ze Li, **a-Lin Yan, Zhao Zhang, Jiong-Lai Chen, Jiang-Yuan Li in BMC Cancer (2024)

  19. Article

    Open Access

    Sequencing of cerebrospinal fluid cell-free DNA facilitated early differential diagnosis of intramedullary spinal cord tumors

    Pre-surgery differential diagnosis is valuable for personalized treatment planning in intramedullary spinal cord tumors. This study assessed the performance of sequencing cell-free DNA (cfDNA) in cerebrospinal...

    Ruichao Chai, Songyuan An, Han Lin, Bo Pang, Hao Yan, Yun Liu in npj Precision Oncology (2024)

  20. Article

    Open Access

    The impact of squamous cell transformation on the prognosis of patients treated with radical nephroureterectomy

    Limited information is available for guiding the management of upper urinary tract (UUT) urothelial carcinoma with squamous differentiation (UC-SqD). We did not even know about the difference between pure uro...

    Li-Hua Huang, Chuan-Shu Chen, Jian-Ri Li, Kun-Yuan Chiu, Shian-Shiang Wang in BMC Cancer (2024)

previous disabled Page of 18